Healthywelth, with all due respect, you are wrong about this old quote being correct;
"medtodamoon Wednesday, 07/20/16 10:25:52 AM
Re: medtodamoon post# 832
Post # of 10585
Here is a fact I can tell you about the approval. It will not come after hours. It will come during the day and the stock will halt for 30 minutes while it is occuring. Seen it in many bios awaiting fda approval. Most do not announce after hours unless they are large companies."
Any pharma that already has a drug FDA approved and selling, when it is reapproved for OTC, there is not a trading halt.
Trading halts are usually only for new FDA drugs approvals, like a major cancer breakthrough drug or another new drug for a different disease, for example.
When GSK and Bayer got OTC approval for Flonase and Clari-spray, there trading was not halted.
When Costco began selling OTC nasal spray, COST stock was not halted.
A new drug FDA approval could come during normal business hours or after business hours or even be announced by a big pharma company on the weekend.
Even if INNV announced that they received ANDA Fluticare OTC approval, it won't halt trading and it might not increase the share price, because it actually could be viewed negatively by the market, because it may require more stock dilution or another stock offer, to raise the capital money, to manufacture, advertise and distribute Fluticare world wide.
At this late point in the game of Dr.Damaje's Fluticare hyping and falsely projected approval dates, the onbly thing likely to bossty INNVs share price is for Damaje to get the SG&A costs down, stop diluting/increasing the available number of INNV shares and get the sales numbers, up, up, up!
News 
Market Data 
Discover 
AI
